UBS analyst UBS maintained a Hold rating on Owens & Minor (NYSE:OMI) on Thursday, setting a price target of $27, which is approximately 6.47% above the present share price of $25.36.
expects Owens & Minor to post earnings per share (EPS) of -$0.91 for the fourth quarter of 2020.
The current consensus among 4 TipRanks analysts is for a Moderate Buy rating of shares in Owens & Minor, with an average price target of $27.75.
The analysts price targets range from a high of $36 to a low of $23.
In its latest earnings report, released on 06/30/2020, the company reported a quarterly revenue of $1.81 billion and a net profit of $28.25 million. The company's market cap is $1.86 billion.
According to TipRanks.com, UBS analyst UBS is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 7.6% and a 59.78% success rate.
Owens & Minor, Inc. is a global healthcare solutions company. It integrates technologies, products, and services aligned to deliver significant and sustained value for healthcare providers and manufacturers across the continuum of care. The firm has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.